Intravenous ketamine therapy in a patient with a treatment-resistant major depression
Swiss Medical Weekly April 21, 2007 Michael Liebrenz, Alain Borgeat, R Leisinger 75 citations
BACKGROUND: Recently, reports from North America have indicated that the intravenous infusion of ketamine hydrochloride (an N-methyl-d-aspartate receptor antagonist) results in a sudden and robust improvement of depression symptoms. OBJECTIVE: To corroborate antidepressant effectiveness of IV ketamine in a patient with a co-occurring substance use disorder for the first time in a European...